Trump Nominates Pro-Life Doctor to be Next FDA Chief

The nomination comes as the FDA is currently conducting a much-anticipated safety review of the abortion drug mifepristone.

Federal Funding to Planned Parenthood Resumes As Pro-Life Leaders Continue Urging Congress to Act

Pro-life leaders are calling on Congress to use the means still at their disposal to implement a permanent freeze.

Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

FDA Confirms It’s Moving Forward with New Phase of Mifepristone Safety Review

‘Every woman deserves the highest standard of medical care,’ said Carol Tobias, president of National Right to Life. ‘We encourage the agency to conduct this review with transparency, scientific integrity, and an unwavering commitment to protecting women.’

U.S. Supreme Court Issues Order Allowing Ongoing Mail-Order Abortion

The move comes after a federal appellate court issued a unanimous ruling earlier this month that – if allowed to take effect – would have blocked mail-order abortion nationwide.

Tagged abortion pillschemical abortionFDALouisianaLouisiana v. FDAmifepristonesupreme court